. QSTAG Inc. - KoreaTechDesk
Published Date: October 20, 2020 ,Last modified on October 28th, 2020

QSTAG Inc.

Colorimetric SensorDisease ScreeningPeriodic POCT technologySmart Urine Testertechnology

QSTAG Inc. develops Smartphone based Urine Tester for personal health screening at Home.

Company Intro Video

Highlights

History and vision  QSTAG Inc is a company that was established in August 2016 and develops rapid kits for personal health screening. Currently, we are developing products through professional researchers with BT, NT, and IT technologies, and our technology is recognized, and we are growing by receiving TIPS investment from Korea Government and pre-A-level investments from NAVER and KB Investments. Currently, we are launching a smart urine test product in South Korea and preparing to enter overseas markets. With B2B co-work based Business Model, such as Fitness company, Contents, Insurance, BMI, Heart rate we will make healthcare consortium. With our service, users can get from basic health management to professional diagnosis. Family related total healthcare platform is our ultimate aim to achieve.   Intellectual property and awards
  • Patents : Registered 6, Applications 31, Brand 2, Certification 3 (ISO13485, GMP, KFDA)
  • Performance : US Branch establishment, Product patent PCT international application, Web Summit Participation
  • Awards : Awarded the Excellence Prize in the Future Growth Engine Challenge (Received from the Ministry of Science, ICT and Future Planning, Korea), Tech Incubator Program for startup Korea (TIPS) Investment
Launching schedule  Currently, KFDA medical device certification is completed in South Korea and officially launched in the South Korean market in June. We are focusing on product marketing to secure genuine customers in the South Korean market. After completing the CE certification by the first half of next year, the process is in progress to promote overseas expansion.

Company Overview

QSTAG Inc is a company that was established in August 2016 and develops rapid kits for personal health screening. We are developing periodic POCT technology for disease screening and monitoring of personal healthcare. Our main product is QSCHECK-UIS which is urine tester combined with QR code and smart phone application for analyzing test results automatically. Current urine tester shows the results by colorimetric method. However, user check the results by naked eyes. Thus, not only is the standard deviation of the results high, it hardly dataizes the results. On the other hands, our product can check the results by smartphone application and make the dataized results.

Problem Overview

Recently, the medical paradigm is changing. Previous medical paradigm is the hospital centered treatment system. But now the medical paradigm is patient-centered management and monitoring their health condition. By this changing, a lot of services has been launched for personal healthcare such as personal genetic services or rapid kits like that..But these services are focused on the prediction of disease No screening, no monitoring. So, customers said that “What’s next ?  And So what?” It means periodic POCT technology is essential for patience centered medical paradigm, for management and monitoring system.     Even this trend, there are a lot of people do not receive health checkups because of their busy schedule and poor welfare services In South Korea, almost 50% of non-regular worker and self-employed do not receive health checkup. These people are not all. People who live in island and mountain area or the other area where is hard to access to hospital or medical institution are also suffer from the same situation. So, to solve this problem, periodic POCT technology is essential.     The 1st generation of POCT technology is used only at hospital such as rapid kit, urine stick, or glucose meter. But 2nd generation POCT technology focus on the personal device for their health condition monitoring. So, this technology should meet datafication for management, high sensitivity for various target disease, disposable at low cost. QSTAG has high technology and our product, QSCHECK, meets all these requirement.

Solution Overview

What is QSCheck-UIS4? We have developed ‘QSCheck-UIS4’ that is urine tester combined with QR code and smart phone application for dataization of the results. Current urine tester shows the results by colorimetric method. However, user check the results by naked eyes. Thus, not only is the standard deviation of the results high, it hardly dataizes the results. On the other hands, our product can check the results by smartphone application and make the dataized results. The product consists of two items, urine cup and stick. After collecting urine with the urine cup, you can dip the stick into urine. Then, just you can get the results by scanning the QR code printed urine stick with smartphone application. Our product detects 4 bio markers including protein, glucose, blood, and ph. These markers indicate abnormalities of kidney, diabetes, and other disease. With urine tester, we have smartphone application QS READER. With this smartphone application test results can be detected automatically and then test results are saved into users smartphone and also sent to the server. The test data can be shared with hospital or other institution. Our device shows excellent performance. The accuracy is almost 95% compared with bench top machine.  

Go-to-Market Strategy and Business Model

  • Market analysis and target customers
In B2C Subscription Business model, the target audience is the general population in their 30s and 40s who are interested in health, and marketing is currently being conducted to target women and the elderly. Customers who are interested in kidney health are also a major target audience. By B2B business with healthcare related companies (insurance company, pet business, fitness etc), we have plan to attract new B2C customers.  
  • Business model
Recently, a medical paradigm has changed from a medical paradigm focusing on the treatment of disease to prevent disease and maintain health. An important goal of our product is to help users monitor their health through urine tests once a month. In B2C strategy, service based on subscription is one of the important business model. In B2B strategy, Through cooperation strategies with healthcare related company such as fitness application, insurance service, we are considering ways to cooperate in product promotion and test results.

Competitive Landscape

To see the rest of the QSTAG Inc. pitch, join now. It's free, quick and easy.

Join Already registered? Log in

Founders' Bio

Donghoon Lee

CEO

Graduated Ph.D. from Sungkyunkwan University /Thin film electronics and sensor experts (17 papers, 7 patents, 21 patents)/ R&D Researcher of Amkor Technology( ~2015) Completed / 2 tasks as a national research director / Various entrepreneurship training and awards

Cheong (Lucas) Shin

CSO

Yonsei Univ. B.S - Chemistry, KAIST M.S - Nanotechnology, SKK GSB - MBA Candidates / Nanobiosensor experts / Business Strategy experts / Various startup entreprenenrship training / Certified Investment Manager

Prof. Ik-Soo Shin

CTO

Professor at Soongsil University / Harvard Medical School Adjunct Professor / Organic electronic materials specialist / Electrochemistry and biosensor

Investors

  • About QSTAG Inc.
  • Website : qstag.com
  • Location : South Korea
  • Founded year : 2016
  • Company size : 20 people
  • Total funding amount: $1.42M
  • Markets: Disease monitoringHealthcare